Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira
Status:
Terminated
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate quality of life changes in Puerto Rican
subjects with Rheumatoid Arthritis treated with Humira (adalimumab) as their first Anti-TNF
Monoclonal Antibody.